Your browser doesn't support javascript.
loading
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.
Merryman, Reid W; Redd, Robert A; Nishihori, Taiga; Chavez, Julio; Nieto, Yago; Darrah, Justin M; Rao, Uttam; Byrne, Michael T; Bond, David A; Maddocks, Kami J; Spinner, Michael A; Advani, Ranjana H; Ballard, Hatcher J; Svoboda, Jakub; Singh, Anurag K; McGuirk, Joseph P; Modi, Dipenkumar; Ramchandren, Radhakrishnan; Romancik, Jason; Cohen, Jonathon B; Frigault, Matthew J; Chen, Yi-Bin; Serritella, Anthony V; Kline, Justine; Ansell, Stephen; Nathan, Sunita; Rahimian, Maryam; Joyce, Robin M; Shah, Mansi; David, Kevin A; Park, Steven; Beaven, Anne W; Habib, Alma; Bachanova, Veronika; Nakhoda, Shazia; Khan, Nadia; Lynch, Ryan C; Smith, Stephen D; Ho, Vincent T; LaCasce, Ann; Armand, Philippe; Herrera, Alex F.
Afiliação
  • Merryman RW; Division of Hematologic Malignancies and.
  • Redd RA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.
  • Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
  • Chavez J; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
  • Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Darrah JM; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Rao U; Cedars-Sinai Medical Center, Los Angeles, CA.
  • Byrne MT; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Bond DA; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Maddocks KJ; Division of Hematology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University Hospital, Columbus, OH.
  • Spinner MA; Division of Hematology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University Hospital, Columbus, OH.
  • Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA.
  • Ballard HJ; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA.
  • Svoboda J; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Singh AK; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • McGuirk JP; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS.
  • Modi D; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS.
  • Ramchandren R; Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI.
  • Romancik J; Division of Hematology/Oncology, University of Tennessee School of Medicine, Knoxville, TN.
  • Cohen JB; Department of Hematology and Medical Oncology, Emory University-Winship Cancer Institute, Atlanta, GA.
  • Frigault MJ; Department of Hematology and Medical Oncology, Emory University-Winship Cancer Institute, Atlanta, GA.
  • Chen YB; Bone Marrow Transplantation Program, Massachusetts General Hospital, Boston, MA.
  • Serritella AV; Bone Marrow Transplantation Program, Massachusetts General Hospital, Boston, MA.
  • Kline J; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
  • Ansell S; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
  • Nathan S; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Rahimian M; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL.
  • Joyce RM; Beth Israel Deaconess Medical Center, Boston, MA.
  • Shah M; Beth Israel Deaconess Medical Center, Boston, MA.
  • David KA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
  • Park S; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
  • Beaven AW; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC.
  • Habib A; Division of Hematology, University of North Carolina, Chapel Hill, NC.
  • Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
  • Nakhoda S; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
  • Khan N; Division of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA; and.
  • Lynch RC; Division of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA; and.
  • Smith SD; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Ho VT; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • LaCasce A; Division of Hematologic Malignancies and.
  • Armand P; Division of Hematologic Malignancies and.
  • Herrera AF; Division of Hematologic Malignancies and.
Blood Adv ; 5(6): 1648-1659, 2021 03 23.
Article em En | MEDLINE | ID: mdl-33710337
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article